ÐÇ¿ÕÓéÀÖ¹ÙÍø

Immunization recommendations

COVID-19

ÐÇ¿ÕÓéÀÖ¹ÙÍø recommends an updated COVID-19 vaccine for most adults ages 18 years and older.

Discuss the benefits of COVID-19 vaccination with parents of children 6 months to 17 years.

Influenza

Everyone 6 months of age and older should receive a seasonal influenza vaccine.

RSV

Infants and pregnant women

All infants should be protected against severe RSV disease through one of the following (only one is indicated in most instances):

• Vaccination (Pfizer Abrysvo only) of pregnant women 32 through 36 weeks of gestation administered during September through January for most of the continental United States.
• Immunization of infants less than 8 months with nirsevimab, a monoclonal antibody administered during October through March (earlier is better) in most of the continental United States.

Children

Some children aged 8 through 19 months at increased risk for severe RSV disease should receive nirsevimab when entering their second RSV season.

Older adults

Everyone 75 years of age and older should receive RSV vaccination if they haven't been previously vaccinated.

Adults 60 through 74 years of age with certain medical conditions or other risk factors that increase their risk for severe RSV disease should receive RSV vaccination if they haven't been previously vaccinated.

Clinical guidance

Best practices for immunizations

View LargerDownload

Detailed ÐÇ¿ÕÓéÀÖ¹ÙÍø guidance

• COVID-19
• Influenza
• RSV

Coadministration of these vaccines

Flu, COVID-19, and RSV vaccines may be co-administered (given at the same visit). They may also be co-administered with other vaccines, in accordance with ÐÇ¿ÕÓéÀÖ¹ÙÍø's general best practices for immunization.

If the provider is confident there will be additional opportunities to vaccinate the patient, and the patient prefers to receive these vaccines during different visits, there is no minimum wait period between these vaccinations.

Preventing vaccine administration errors

A vaccine administration error is any preventable event that may cause or lead to inappropriate medication use or patient harm. Take preventive actions to avoid vaccine administration errors and establish an environment that values reporting and investigating errors as part of risk management and quality improvement.

• Vaccine administration: Preventing vaccine administration errors
• COVID-19: Vaccine administration errors and deviations

Testing and treatment

Testing

• COVID-19
  • Testing overview for SARS-CoV-2
  • Rapid testing in point-of-care settings
• COVID-19 and influenza
  • When SARS-CoV-2 and influenza viruses are co-circulating
• Influenza
  • Rapid influenza diagnostic tests

Treatment

Assess whether the patient has risk factors that place them at higher risk for severe flu and COVID-19 and should therefore receive prescription antiviral medications if they become ill.

• COVID-19
  • Clinical care for outpatients
• Influenza
  • Antiviral medications: Summary for clinicians